Thursday, June 19th, 2025
Stock Profile: QNTM

Quantum BioPharma Ltd. (QNTM)

Market: NASD | Currency: USD

Address: 55 University Ave.

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, Show more




📈 Quantum BioPharma Ltd. Historical Chart






📊 Statistics





💰 Dividend History


Year Annual Yield (%) Total Amount Current Yield (%) Ex Date Pay Date Particulars
2024 - $0.015385 - 2024-08-15 - Stock split
Total Amount for 2024: $0.015385
2019 - $0.004975 - 2019-10-16 - Stock split
Total Amount for 2019: $0.004975


📅 Earnings & EPS History for Quantum BioPharma Ltd.


DateReported EPS
2026-05-12 (estimated upcoming)-
2026-03-26 (estimated upcoming)-
2025-11-10 (estimated upcoming)-
2025-08-12 (estimated upcoming)-
2025-05-14-2.96
2025-05-12-
2025-03-28-
2024-11-11-4.18
2024-08-14-5.2




📰 Related News & Research


No related articles found for "quantum biopharma".